Cytokines Released from activated human macrophages induce epithelial mesenchymal transition markers of Cholangiocarcinoma cells

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue SUPPL.1, 2012, Pages 115-118

  Techasen, Anchalee ^a,b   Loilome, Watcharin ^a,b   Namwat, Nisana ^a,b   Dokduang, Hasaya ^a,b   Jongthawin, Jurairat ^a,b   Yongvanit, Puangrat ^a,b  

^a KHON KAEN UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Cholangiocarcinoma; Epithelial mesenchymal transition; Macrophage derived cytokines; Macrophages

Indexed keywords

CADHERIN; CYTOKINE; TRANSFORMING GROWTH FACTOR BETA1;

BILE DUCT CARCINOMA; BILE DUCT TUMOR; CELL MOTION; DRUG EFFECTS; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; INTRAHEPATIC BILE DUCT; MACROPHAGE; METABOLISM; TUMOR CELL LINE;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; CHOLANGIOCARCINOMA; CYTOKINES; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; MACROPHAGES; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84874100938     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.KKSuppl.115     Document Type: Article

References (29)

1. Bakin AV, Tomlinson AK, Bhowmick NA, et al (2000). Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem, 275, 36803-10.
2. Balkwill F, Mantovani A (2001). Inflammation and cancer: back to Virchow? Lancet, 357, 539-45.
3. Bates RC, Mercurio AM (2003). Tumor necrosis factor-alpha stimulates the epithelial-to-mesenchymal transition of human colonic organoids. Mol Biol Cell, 14, 1790-800.
4. Bingle L, Brown NJ, Lewis CE (2002). The role of tumourassociated macrophages in tumour progression: implications for new anticancer therapies. J Pathol, 196, 254-65.
5. Chen JJ, Lin YC, Yao PL, et al (2005). Tumor-associated macrophages: the double-edged sword in cancer progression. J Clin Oncol, 23, 953-64.
6. Chuang MJ, Sun KH, Tang SJ, et al (2008). Tumor-derived tumor necrosis factor-alpha promotes progression and epithelialmesenchymal transition in renal cell carcinoma cells. Cancer Sci, 99, 905-13.
7. Coussens LM, Werb Z (2002). Inflammation and cancer. Nature, 420, 860-7.
8. Fujii-Maeda S, Kajiwara K, Ikizawa K, et al (2004). Reciprocal regulation of thymus and activation-regulated chemokine/macrophage-derived chemokine production by interleukin (IL)-4/IL-13 and interferon-gamma in HaCaT keratinocytes is mediated by alternations in E-cadherin distribution. J Invest Dermatol, 122, 20-8.
9. Gal A, Sjoblom T, Fedorova L, et al (2008). Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis. Oncogene, 27, 1218-30.
10. Jedinak A, Dudhgaonkar S, Sliva D (2010). Activated macrophages induce metastatic behavior of colon cancer cells. Immunobiology, 215, 242-9.
11. Kerr KM, Johnson SK, King G, et al (1998). Partial regression in primary carcinoma of the lung: does it occur? Histopathology, 33, 55-63.
12. Ko SC, Chapple KS, Hawcroft G, et al (2002). Paracrine cyclooxygenase-2-mediated signalling by macrophages promotes tumorigenic progression of intestinal epithelial cells. Oncogene, 21, 7175-86.
13. Leek RD, Lewis CE, Whitehouse R, et al (1996). Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res, 56, 4625-9.
14. Mukai M, Shinkai K, Tateishi R, et al (1987). Macrophage potentiation of invasive capacity of rat ascites hepatoma cells. Cancer Res, 47, 2167-71.
15. Nawshad A, Lagamba D, Polad A, et al (2005). Transforming growth factor-beta signaling during epithelial-mesenchymal transformation: implications for embryogenesis and tumor metastasis. Cells Tissues Organs, 179, 11-23.
16. Pollard JW (2004). Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer, 4, 71-8.
17. Radisky DC, Levy DD, Littlepage LE, et al (2005). Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature, 436, 123-7.
18. Sato Y, Harada K, Itatsu K, et al (2010). Epithelial-mesenchymal transition induced by transforming growth factor- {beta}1/Snail activation aggravates invasive growth of cholangiocarcinoma. Am J Pathol, 177, 141-52.
19. Subimerb C, Pinlaor S, Khuntikeo N, et al (2010). Tissue invasive macrophage density is correlated with prognosis in cholangiocarcinoma. Mol Med Report, 3, 597-605.
20. Sullivan NJ, Sasser AK, Axel AE, et al (2009). Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells. Oncogene, 28, 2940-7.
21. Tanimura Y, Kokuryo T, Tsunoda N, et al (2005). Tumor necrosis factor alpha promotes invasiveness of cholangiocarcinoma cells via its receptor, TNFR2. Cancer Lett, 219, 205-13.
22. Techasen A, Namwat N, Loilome W, et al (2012). Tumor necrosis factor-alpha (TNF-alpha) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma. Med Oncol, 29, 3083-91.
23. Thiery JP, Acloque H, Huang RY, et al (2009). Epithelialmesenchymal transitions in development and disease. Cell, 139, 871-90.
24. Torisu H, Ono M, Kiryu H, et al (2000). Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFalpha and IL-1alpha. Int J Cancer, 85, 182-8.
25. Vincent T, Neve EP, Johnson JR, et al (2009). A SNAIL1- SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition. Nat Cell Biol, 11, 943-50.
26. Wu Y, Deng J, Rychahou PG, et al (2009). Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. Cancer Cell, 15, 416-28.
27. Yadav A, Kumar B, Datta J, et al (2011). IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway. Mol Cancer Res, 9, 1658-67.
28. Yang J, Weinberg RA (2008). Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell, 14, 818-29.
29. Yilmaz M, Christofori G (2009). EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev, 28, 15-33.